The confirmed financials show 2022 as the cycle peak: revenue of KRW 1,697.5bn, operating profit of KRW 352.4bn (20.8% margin) and net profit attributable to owners of KRW 245.8bn.
The company then posted two consecutive loss years, with 2023 revenue of KRW 1,041.9bn and an operating loss of KRW 88.1bn, and 2024 revenue of KRW 1,231.4bn with an operating loss of KRW 47.0bn, before 2025 revenue of KRW 1,410.6bn and operating profit of KRW 11.9bn (0.8% margin) returned the operating line to black.
The 2025 net loss attributable to owners nevertheless widened to KRW 164.2bn, driven mainly by a KRW 116.7bn quarterly net loss in 4Q 2025 even though that quarter carried KRW 10.3bn of operating profit.
The quarterly trend is clearly improving: from KRW 340.8bn revenue and KRW 5.5bn operating profit (1.6%) in 2Q 2025, to KRW 372.8bn and KRW 12.4bn in 3Q 2025, KRW 393.4bn and KRW 10.3bn in 4Q 2025, KRW 422.4bn and KRW 13.7bn (3.2%) in 1Q 2026, and KRW 514.6bn and KRW 62.9bn (12.2%) in 2Q 2026.
First-half 2026 operating profit of KRW 76.6bn is more than six times the full-year 2025 figure.
On the drivers, Kiwoom Securities pointed to higher plant utilization and increased shipments of high-value products such as MSAP packaging substrates and SOCAMM, while brokerages commonly cited a richer high-value product mix, higher average selling prices and better utilization.
The balance sheet improved, with the debt-to-equity ratio falling from 221.8% in 2024 to 181.1% in 2025 and total equity rising from KRW 448.5bn to KRW 576.4bn, an increase that includes the equity treatment of a KRW 50bn perpetual convertible bond issued in June 2025.
By contrast, on the confirmed data provided, operating cash flow was negative for three straight years at KRW -93.4bn in 2023, KRW -161.3bn in 2024 and KRW -198.6bn in 2025, so the lag between earnings recovery and cash flow recovery warrants monitoring.